(NASDAQ:RVPH), – Robust broad-spectrum efficacy sustained over 1-year across all symptom domains including negative symptoms – – Generally well-tolerated with low rates of adverse events and discontinuation – – Brilaroxazine improved multiple neuroinflammatory markers reported to enhance efficacy and mitigate side effects – – Virtual investor webcast today at 8:00 a.m. EDT – CUPERTINO, Calif., […]

(NasdaqGM:KYMR), Phase 1 healthy volunteer data of KT-621, a once-a-day STAT6 degrader, surpass Kymera's target product profile, significantly derisking program and further validating its oral, biologics-like profile >90% mean STAT6 degradation in blood achieved at all doses above 1.5 mg Complete STAT6 degradation achieved in both blood and skin at all MAD doses greater-than or

(CNSX:RSG.CN),(Pinksheets:CNOBF),(PinkSheets:CNOBF), TORONTO, June 02, 2025 (GLOBE NEWSWIRE) — Rocky Shore Gold Ltd. (the “Company”) (CSE:RSG) is pleased to announce that it has entered into a definitive agreement (the “Agreement”) with a subsidiary of Barrick Mining Corporation (“Barrick”) to sell its Hemlo-area mineral claims near Marathon, Ontario for cash consideration of CAD$975,000 (the “Transaction”). This Agreement

(NASDAQ:VFF), – Closing of transaction places Company in net cash position, poised for leadership in global cannabis industry – – Company plans to file proforma financial statements excluding discontinued operations within four business days – VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) — Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF)

(NASDAQ:JBIO), SAN FRANCISCO and VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) — Jade Biosciences, Inc. (“Jade”) (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced new preclinical data on JADE101, its anti-APRIL monoclonal antibody being developed for the treatment of IgA nephropathy (IgAN), will be presented in an

SAVANNAH, Ga. and TORONTO, June 02, 2025 (GLOBE NEWSWIRE) — Nokia and Andorix, a provider of digital infrastructure and smart building solutions for real estate properties, announced a partnership to accelerate the adoption of private 5G networks and Neutral Host Networks in the real estate market across the United States and Canada. Real estate owners

PALO ALTO, Calif., June 02, 2025 (GLOBE NEWSWIRE) — Denodo, a leader in data management, announced that the Denodo Academic Program, which prepares students to become future leaders in the field of data and analytics, has opened registration for the next University Challenge, Data and AI for Real-World Impact, with registration closing on November 16.

(NASDAQ:TIL), DALLAS, June 02, 2025 (GLOBE NEWSWIRE) — Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel cancer therapies, today announced the appointment of Jamie Freedman, M.D., Ph.D., as Chief Medical Officer. Dr. Freedman brings deep experience in oncology drug development and other therapeutic areas, and a

(NASDAQ:LYRA), ENLIGHTEN 2 trial met primary endpoint with LYR-210 demonstrating statistically significant improvement in the composite of the three cardinal symptoms (3CS) of CRS at 24 weeks (p=0.0078) ENLIGHTEN 2 trial also showed statistically significant improvement in key secondary endpoints in the full population of 3CS at 24 weeks (p=0.0209) and SNOT-22 score at 24

–Completion of GLP toxicology studies associated with a $50 million payment to Recludix under the collaboration with Sanofi — REX-8756 is a potent and selective oral STAT6 inhibitor that demonstrates complete pathway inhibition and is well tolerated in preclinical studies –Investigational New Drug (IND)-enabling activities ongoing to support IND submission later this year SAN DIEGO,